# LYNKUET
> **NDA219469** · New Drug Application · Sponsor: BAYER HLTHCARE · Approved 2025-10-24
## Drug
- **FDA Application Number:** NDA219469
- **Application type:** New Drug Application
- **Brand name:** LYNKUET
- **Generic name:** ELINZANETANT
- **Active ingredients:** ELINZANETANT
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BAYER HLTHCARE
- **Manufacturer:** Bayer HealthCare Pharmaceuticals Inc.
- **First approval:** 2025-10-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219469)
---
*AI Analytics · CC0 1.0*